Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
02/2003
02/20/2003WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia
02/20/2003WO2003014333A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering
02/20/2003WO2003014326A2 Isolation and mobilization of stem cells expressing vegfr-1
02/20/2003WO2003014322A2 Proteins associated with cell growth, differentiation, and death
02/20/2003WO2003014321A2 Compositions and methods for modulation of darpp-32 phosphorylation
02/20/2003WO2003014318A2 Methods for treating diabetes and other blood sugar disorders
02/20/2003WO2003014309A2 Interleukin-1 receptors in the treatment of diseases
02/20/2003WO2003014301A2 Hprp4s as modifiers of the p53 pathway and methods of use
02/20/2003WO2003014300A2 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
02/20/2003WO2003014299A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
02/20/2003WO2003014294A2 Tacis and br3 polypeptides and uses thereof
02/20/2003WO2003014161A2 Antigen binding domains from fish
02/20/2003WO2003014159A1 Methods of screening based on the egf receptor crystal structure
02/20/2003WO2003014158A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
02/20/2003WO2003014145A2 Peptides that bind to atherosclerotic lesions
02/20/2003WO2003014144A2 Molecule
02/20/2003WO2003014137A1 Adenosine a3 receptor agonists
02/20/2003WO2003014125A1 Therapeutically useful tetracyclic ligands
02/20/2003WO2003014124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists
02/20/2003WO2003014123A1 Tricyclic imidazopyridines
02/20/2003WO2003014118A1 THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
02/20/2003WO2003014114A2 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
02/20/2003WO2003014112A1 Crystal and process for producing the same
02/20/2003WO2003014111A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014110A1 Benzazepine derivative, process for producing the same, and use
02/20/2003WO2003014105A1 Bicyclic compound, production and use as hiv inhibitors
02/20/2003WO2003014101A1 Hydroxamic acid derivatives
02/20/2003WO2003014098A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014097A1 Arylsulfonyl derivatives with 5-ht6 receptor affinity
02/20/2003WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014091A1 Pyrimidine derivatives as selective inhibitors of cox-2
02/20/2003WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
02/20/2003WO2003014083A1 Spiro compounds
02/20/2003WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors
02/20/2003WO2003014075A2 Novel gamma secretase inhibitors
02/20/2003WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
02/20/2003WO2003013655A2 Carbonic anhydrase inhibitors
02/20/2003WO2003013647A2 Electrodes coated with treating agent and uses thereof
02/20/2003WO2003013609A1 Sustained-release medicines
02/20/2003WO2003013605A1 Remedies for prostatic diseases
02/20/2003WO2003013603A1 Modulators of p-selectin glycoprotein ligand 1
02/20/2003WO2003013602A1 Inhibitors of her3 activity
02/20/2003WO2003013588A1 Kidney regeneration material comprising cells and cell growth factor
02/20/2003WO2003013586A1 Access control system
02/20/2003WO2003013577A2 Use of il-18 inhibitors in hypersensitivity disorders
02/20/2003WO2003013571A1 Peptidomimetics of biologically active metallopeptides
02/20/2003WO2003013564A2 An herbal composition for the treatment and remedy of bronchial respiratory difficulties
02/20/2003WO2003013562A1 Artichoke leaf extracts
02/20/2003WO2003013559A1 Bile acid absorbent/adsorbent
02/20/2003WO2003013554A2 Aromatase inhibitors from broussonetia papyrifera
02/20/2003WO2003013550A1 Micronutrient phosphates as dietary and health supplements
02/20/2003WO2003013549A2 Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003WO2003013541A1 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
02/20/2003WO2003013540A1 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia
02/20/2003WO2003013537A2 Irinotecan for treatment of cancer
02/20/2003WO2003013536A2 Methods for treatment of cancer using irinotecan based on ugt1a1
02/20/2003WO2003013535A2 Use of irinotecan for improved treatment of cancer based on mdr1
02/20/2003WO2003013534A2 Methods for the treatment of cancer with irinotecan based on cyp3a5
02/20/2003WO2003013533A2 Methods for improved treatment of cancer with irinotecan based on mrp1
02/20/2003WO2003013532A1 Chiral dinapsoline
02/20/2003WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
02/20/2003WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors
02/20/2003WO2003013525A1 Opioid agonist formulations with releasable and sequestered antagonist
02/20/2003WO2003013522A1 Preventives/remedies for cholinergic neuropathy
02/20/2003WO2003013521A1 Compounds for eliminating and/or relieving anhedonia
02/20/2003WO2003013520A1 Pramipexole for the treatment of adhd
02/20/2003WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
02/20/2003WO2003013517A1 Aminoisoxazole derivatives active as kinase inhibitors
02/20/2003WO2003013515A1 Novel alpha adrenergic agents
02/20/2003WO2003013513A1 Stable emulsion composition
02/20/2003WO2003013512A2 Crystalline forms of fluvastatin sodium
02/20/2003WO2003013510A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
02/20/2003WO2003013494A1 Remedial agent for arthrosis deformans
02/20/2003WO2003013493A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
02/20/2003WO2003013485A1 Inhibitors of hb-egf (erbb) receptors for treating myeloma
02/20/2003WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
02/20/2003WO2003013477A1 Drug release system for controlled therapy
02/20/2003WO2003013475A1 Injectable foam and novel pharmaceutical applications thereof
02/20/2003WO2003013473A1 Stabilized oral suspension formulation
02/20/2003WO2003013470A1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt
02/20/2003WO2003013458A1 Cosmetic and/or pharmaceutical preparations containing plant extracts
02/20/2003WO2003013445A1 Nanocapsules containing a steroid for cosmetic compositions
02/20/2003WO2003013438A2 Nutrient therapy for immuno-compromised patients
02/20/2003WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace
02/20/2003WO2003013422A2 Methods for the treatment and prognosis of leukemia and other cancer types
02/20/2003WO2003013277A1 Chitosan-containing powder
02/20/2003WO2002100858A3 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
02/20/2003WO2002099138A3 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE
02/20/2003WO2002098427A3 Sustained-release analgesic compounds
02/20/2003WO2002096927A3 Ribozyme based treatment of female reproductive diseases
02/20/2003WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
02/20/2003WO2002092758A8 Gastrokines and derived peptides including inhibitors
02/20/2003WO2002086085A3 Human timp-1 antibodies
02/20/2003WO2002085368A3 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
02/20/2003WO2002076437A3 Methods for treating neurodegenerative diseases including alzheimer's
02/20/2003WO2002074742A3 Cdk-inhibitory indirubin derivatives having an increased solubility
02/20/2003WO2002072003A3 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour
02/20/2003WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof
1 ... 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 ... 1564